STAAR Surgical is trading at $24.79 (14.5% down) in after-hours sessions, a sharp reversal from its late-May strength following the termination of the Alcon acquisition and subsequent shareholder pushback.
- The move marks a significant pullback from the stock's recent rally which was fueled by strong Q1 earnings results.
- Market sentiment remains weighed down by prior volatility surrounding M&A guidance and the collapse of the deal with Alcon.
- There is no fresh company-specific headline immediately tied to the July 17 price action, suggesting potential technical selling or a delayed reaction to recent deal uncertainty.